Table 1.
Type | Mechanism | Skeletal Site | Type of Bone Disease | CKD Stage |
---|---|---|---|---|
Plain Radiography | Bone resorption lesions Bone cysts Fractures |
Sub-periosteal Subchondral Sub-tendinous Extra-skeletal calcifications All skeleton |
Secondary Hyperparathyroidism Multiple Myeloma Amyloidosis Osteonecrosis Osteoporosis Calcific Uremic Arteriolopathy |
All |
DXA | Areal BMD measurements | Hip, distal radius, lumbar spine, whole body | Osteopenia Osteoporosis |
All |
Vertebral Assessment Fracture (VAF) | Vertebral deformities | Spine | Vertebral fractures | All |
HR-pQCT | Trabecular architecture Volumetric BMD | Hip, distal radius, distal tibia | Secondary Hyperparathyroidism | All and research |
Bone Scintigraphy | Tracer accumulation occurs in osteoblastic activity, and to a lesser extent, skeletal vascularity; Systemic amyloid burden; |
Whole body | Osteoarthritis Metabolic Bone Disease: -Hyperparathyroidism and vitamin D deficiency -Osteomalacia; Fractures Enthesopathies Osteonecrosis Rare Osteoarticular Diseases: Sarcoidosis with bone involvement; Amyloidosis: 123I SAP scintigraphy if available—assess amyloid deposition in liver, spleen, kidneys, adrenals, localized soft tissue deposits and bones 131I-β2M amyloidosis |
3–5 |
MRI | Cortical porosity Marrow fat content and composition Marrow perfusion, and molecular diffusion |
Distal radius, distal tibia, calcaneus, hip, spine Whole skeleton |
Secondary Hyperparathyroidism | Research |
PET | Bone formation rate, osteoclast, osteoblast, erosion and mineralized surfaces | Lumbar region | Low or high bone turnover disease | All |
US | Cortical deterioration | Tibia | Secondary Hyperparathyroidism | Research |
DXA, Dual-energy X-ray Absorptiometry; BMD, Bone Mineral Density; HR-pQCT, High Resolution-peripheral Quantitative Computerized Tomography; MRI, Magnetic Resonance Image; PET, Positron Energy Tomography; US, Ultrasounds Velocity.